University of Monastir

um.rnu.tn

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

110

Active

15

Phase 3

27

Total enrollment

78,215

Pipeline matrix

Showing 17 of 17 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Magnesium Sulfate3
atherolive2
Hypertonic sodium chloride 10%1
Sodium Chloride 0.9%1
Furosemide intravenous solution1
Atherolive 500mg/day1
Atherolive 1000/day1
Placbo_Atherolive1
Gelafundin1
Saline1
Terbutaline 2.5 mg1
Dexamethasone1
Piroxicam2
Acetaminophen1
paracétamol tramadol1
Paracétamol cafeine1
Mini bolus 501

Next readouts

  • 2024-08-22
  • 2025-03-15
  • 2025-08-30
  • 2025-09-15
  • 2025-12-01
  • 2025-12-30
  • 2027-06
  • 2027-11-30
  • 2027-12-01

Top conditions

  • Renal Colic10
  • Acute Heart Failure8
  • Acute Coronary Syndrome5
  • Acute Pain5
  • COPD Exacerbation5
  • Heart Failure3
  • Emergencies3
  • Chronic Obstructive Pulmonary Disease3

Frequently asked questions about University of Monastir

How many clinical trials does University of Monastir have on ClinicalTrials.gov?
University of Monastir is listed as the lead sponsor on 110 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
How many of University of Monastir's trials are in Phase 3?
27 of University of Monastir's trials are in Phase 3, spread across 17 active drug programs.
What therapeutic areas does University of Monastir focus on?
University of Monastir's most-studied conditions on ClinicalTrials.gov are Renal Colic, Acute Heart Failure, Acute Coronary Syndrome, Acute Pain, COPD Exacerbation.
When are University of Monastir's next clinical trial readouts?
University of Monastir has 9 upcoming primary-completion readouts tracked here; the soonest is “Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department”, expected around 2024-08-22.